Insulet
PODD
#1256
Rank
S$22.90 B
Marketcap
S$325.42
Share price
0.27%
Change (1 day)
-14.56%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): S$0.47 Billion

According to Insulet's latest financial reports the company's current earnings are S$2.52 Billion. In 2024 the company made an earning of S$0.43 Billion, an increase over its 2023 earnings that were of S$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.47 B9.93%
2024 S$0.43 B36.76%
2023 S$0.31 B481.9%
2022 S$54.82 M-45.24%
2021 S$0.10 B43.35%
2020 S$69.83 M18.51%
2019 S$58.93 M41.16%
2018 S$41.74 M-711.95%
2017 -S$6.83 Million-56.85%
2016 -S$15.82 Million-79.31%
2015 -S$76.44 Million63.85%
2014 -S$46.65 Million31.04%
2013 -S$35.6 Million-21.96%
2012 -S$45.62 Million
2010 -S$43.51 Million-42.38%
2009 -S$75.52 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$68.5 Million209.75%
2006 -S$22.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.21 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.35 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$8.15 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$28.62 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$0.27 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$0.15 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.24 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA